Prevalence and Antibiogram of Rothia mucilaginosa and Staphylococcus spp Isolated from Oral Cavity of Students in a Tertiary Institution

N. P. Akani *

Department of Microbiology, Faculty of Science, Rivers State University, Nkpolu-Oroworukwo, P. M. B. 5080, Port Harcourt, Nigeria.

S. C. Amadi

Department of Microbiology, Faculty of Science, Rivers State University, Nkpolu-Oroworukwo, P. M. B. 5080, Port Harcourt, Nigeria.

P. N. Barika

Department of Microbiology, Faculty of Science, Rivers State University, Nkpolu-Oroworukwo, P. M. B. 5080, Port Harcourt, Nigeria.

A. A. Akintola

Department of Microbiology, Faculty of Science, Rivers State University, Nkpolu-Oroworukwo, P. M. B. 5080, Port Harcourt, Nigeria.

*Author to whom correspondence should be addressed.


Bacteremia and systemic infection caused by Rothia mucilaginosa and Staphylococcus spp are uncommon and their resistance to antibiotics are becoming overwhelming. Hence, this study was carried out to investigate the prevalence and antibiogram of Rothia mucilaginosa and Staphylococcus spp from oral cavity of students in a Tertiary Institution. A total of fifty (50) specimen were collected from the oral cavity of male and female students in Rivers State University and subjected to standard microbiological procedures such as culturing, isolation, identification as well as antibiotic susceptibility test. Sixty-seven (67) bacterial isolates were identified with Staphylococcus aureus 43(64.2%) occurring most, followed by  Rothia  mucilaginosa 18(26.7%) and Staphylococcus  epidermidis 6(8.9%). All the isolates of Rothia mucilaginosa, Staphylococcus aureus and Staphylococcus epidermidis were positive for the presence of haemolysin and catalase enzymes. The results of the percentage occurrence among male and female students revealed that Staphylococcus aureus had the highest occurrence (64.18%:59.38%) followed closely by Rothia mucilaginosa (22.86%:31.25%) while Staphylococcus epidermidis had the least prevalence (8.95%:9.37%) in male and female respectively. The result of the susceptibility patterns showed that majority of Staphylococcus aureus, Staphylococcus epidermidis and Rothia mucilaginosa were highly sensitive to ciprofloxacin (90.70%; 100%; 83.33%) and gentamicin (76.74%; 83.33%: 100%), and highly resistant to azithromycin (44.19% and 66.67%) for Staphylococcus aureus, Staphylococcus epidermidis and Rothia mucilaginosa were highly resistant to ampiclox (61.11%). The results of multiple antibiotic resistance (MAR) indices, showed that 86.05% of S. aureus;  83.33% of R. mucilaginosa and 100% of S. epidermidis had MAR indices ≥ 0.2. This study displays serious threat to public health because these microorganisms which showed some virulent factors such as production of haemolysin and catalase enzymes may cause life threatening infections in immunocompromised persons. The indiscriminate use of antibiotics to prevent increased antimicrobial resistance is advocated.

Keywords: Antibigram, prevalence, Rothia mucilaginosa, oral cavity and Multiple Antibiotic Resistance (MAR) index

How to Cite

Akani , N. P., Amadi , S. C., Barika , P. N., & Akintola , A. A. (2023). Prevalence and Antibiogram of Rothia mucilaginosa and Staphylococcus spp Isolated from Oral Cavity of Students in a Tertiary Institution. South Asian Journal of Research in Microbiology, 15(1), 27–35.


Download data is not yet available.


Fanourgiakis P, Georgala A, Vekemans M, Daneau D, Heymans C, Aoun M. "Bacteremia due to Stomatococcus mucilaginosus in neutropenic patients in the setting of a cancer institute". Clinical Microbiology and Infection. 2003;9(10):1068–1072.

Maraki S, Papadakis IS. Rothia mucilaginosa pneumonia: A literature review. Infectious Disease. 2015;47(3):125-129.

Hayat A, Thaneeru P. Rothia mucilaginosa: A rare cause of peritoneal dialysis-related peritonitis. New Zealand Medicinal Journal. 2013;126:118-120.

Li Y, Kawamura Y, Fujiwara N, Naka T, Liu H, Huang X, Kobayashi K, Ezaki T. Rothia aeria sp. nov, Rhodococcus baikonurensis sp. 2003:213-324.

Sadikot Ruxana T, Yuan Zhihong, Panchal Dipti, Syed Mansoor Ali, Mehta Hiren, Joo Myungsoo, Hadid Walid. Induction of cyclooxygenase-2 signaling by Stomatococcus mucilaginosus highlights the pathogenic potential of an oral commensal. The Journal of Immunology. 2013;191(7):12-18.

Almuzara MN, Mariñansky AL, Valenzuela VC, Vay CA. Endocarditis due to Rothia dentocariosa complicated by septic cerebral embolism. Enfermiology Infection on Microbiology and Clinical. 2004;22:255-256.

Ochi F, Tauchi H, Moritani K. Rothia mucilaginosa infection in a child with acute lymphoblastic leukemia. Pediatric Blood & Cancer. 2017;64(1):205-206.

Schultsz C, Geerlings S. Plasmid-mediated resistance in enterobacteriaceae. Changing Landscape and Implications for Therapy. Drugs. 201272:1-16.

Verall AJ, Robinson PC, Tan CE, Mackie WG, Blackmore TK. Rothia aeria as a cause of sepsis in a native joint. Journal of Clinical Microbiology. 2010;48:2648-2650.

Xiong ZJ, Zhang JL, Zhang DF, Zhou ZL, Liu MJ, Zhu WY, Zhao LX, Xu LH, Li WJ. Rothia endophytika sp. nov, an actinobacterium isolated from Dysophylla stellata (Lour.) Benthoic International Journal on System Evolutional Microbiology. 2013;63:3964-3969.

Rigauts C, Aizawa J, Taylor SL, Rogers GB, Govaerts M, Cos P, Ostyn L, Sims S, Vandeplassche E, Sze M, Dondelinger Y, Vereecke L, Van Acker H, Simpson JL, Burr L, Willems A, Tunney MM, Cigana C, Bragonzi A, Coenye T, Crabbé A. Rothia mucilaginosa is an anti-inflammatory bacterium in the respiratory tract of patients with chronic lung disease. European Respiratory Journal. 2022;59(5): 2101293.

Tong SY, Schaumburg F, Ellington MJ, Corander J, Pichon B, Leendertz F, Bentley SD, Parkhill J, Holt DC, Peters G, Giffard PM. "Novel staphylococcal species that form part of a Staphylococcus aureus-related complex: The non-pigmented Staphylococcus argenteus sp. nov. and the non-human primate-associated Staphylococcus schweitzeri sp. nov". International Journal of Systematic and Evolutionary Microbiology. 2015;65(1): 15–22.

Collins MD, Hutson RA, Baverud V, Falsen E. Characterization of a rothia-like organism from a mouse: Description of Rothia nasimurium sp. nov. and reclassification of Stomatococcus mucilaginosus as Rothia mucilaginosa comb. nov. International Journal of Systematic and Evolutionary Microbiology; 2000.

Funke G, Bernard KA, Coryneform. Gram-positive rods. In Manual of Clinical Microbiology. 10th edition. Edited by Versalovic J, Carroll KC. Washington DC: ASM press. 2011;1:413-442.

Gosmanova EO, Garret TR, Wall BM. Peritonitis caused by Rothia mucilaginosa in a Perytoneal dialysis patient. Amateur Journal of Medical Science. 2013;346:517-518.

Laxminarayan R, Brown CM. Economics of antibiotic resistance: A theory of optimal use of Escherichia coli. Journal on Environmental Economics Management. 2001;42(2):183-206.

Cheesbrough M. District laboratory practice in tropical countries. Cambridge University Press. 2006:62.

Clinical and Laboratory Standard Institute. Performance Standards for Antimicrobial Susceptibility Testing, Twenty-first Informational Supplement. CLSI document M100-S21 (ISBN1-56238-742-1) Clinical and Laboratory Standards Institute, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087 USA. 2017;30(1):68-70.

Krumperman PH. Multiple antibiotic indexing of E. coli to identify high-risk sources of fecal contamination of foods. Applied and Environmental Microbiology. 1985;46:165–170.

Bewick V, Cheek L, Ball J. Statistics review 9: One-way analysis of variance. Critical Care. 2004;8(2):130–136.

Emmanuel ON, Magaji SN. Antibiotic sensitivity pattern of Staphylococcus aureus from clinical isolates in a tertiary health institution in Kano, Northwestern Nigeria. The Pan African Medical Journal. 2011;8:4-8.

Nurain AM, Bilal NE. Ibrahim ME. The frequency and antimicrobial resistance patterns of nosocomial pathogens recovered from cancer patients and hospital environments. Asian Pacific Journal of Tropical Biomedicine. 2015;5: 1055-1059.

Klem-Patel ME, Diamond G, Boniotto M, Saad S, Ryan LK. Inhibition of p-Defensin gene expression in airway epithelial cells by lowdoses of residual oil fly ash is mediated by vanadium. Oxford Journal of Life Sciences & Med Toxicology Science. 2006:92:119-125.

Tsuzukibashi O, Uchibori S, Kobayashi T. Isolation and identification methods of Rothia species in oral cavities. Journal of Microbiological Methods. 2017;134:21-26.

Robertson RD, Panigrahi A, Cheema R. Rothia mucilaginosa bacteremia, meningitis leading to diffuse cerebritis in an adolescent patient undergoing acute myeloid leukemia chemotherapy causing significant morbidity. SAGE Open Medical Case Representatives; 2021.

Sharma U, Schwan WR, Agger WA. Escherichia Coli pyomyositis in an immunocompromised host. Wmj: Official Publication of the State Medical Society of Wisconsin. 2011;110:182.

Bensel T, Stotz M, Borneff-Lipp M, Wollschläger B, Wienke A. Lactate in cystic fibrosis sputum. Journal of Cystic Fibrosis. 2011;10:37–44.

Bibashi E, Kokolina E, Mitsopoulos E, Kontopoulou K, Sofianou D. Peritonitis due to Rothia dentocariosa in a patient receiving continuous ambulatory peritoneal dialysis. Clinical Infection and Disease. 2009:28:696.

Binder D, Zbinden R, Widmer U, Opravil M, Krause M. Native and prosthetic valve endocarditis caused by Rothia dentocariosa: Diagnostic and therapeutic considerations. Infection. 2007;25:22-26.

Boudewijns M, Magerman K, Verhaegen J, Debrock G, Peetermans WE, Donkersloot P, Mewis A, Peeters V, Rummens JL. Cartuyvels and R. Rothia dentocariosa, endocarditis and mycotic aneurysms: A case report and review of the literature. Clinical Microbiology on Infection and Disease. 2008;9:222-229.

Cheesbrough M. Microbiological test district laboratory practice in tropical countries. In: Cremer A, Evan G, (eds). Cambridge University Press, UK. 2000:1-226.

Cheesbrough M. District laboratory practice in tropical countries, part 2. Cambridge University Press, Cambridge. 2005:159-162.

Lebea MM, Davies V. Evaluation of culture proven neonatal sepsis at a tertiary care hospital in Johannesburg, South Africa. South African Journal of Child Health. 2017;11:170-173.

Weinstein RA. Controlling antimicrobial resistance in hospitals: Infection control and use of antibiotics. Emerging Infectious Diseases. 2001;7:188.

Davis R, Brown PD. Multiple antibiotic resistance index, fitness and virulence potential in respiratory Pseudomonas aeruginosa from Jamaica. Journal of Medical Microbiology. 2016;65:261–271.